SOCRATES-REDUCED (Klaar) Phase IIb safety and efficacy study of four dose regimens of BAY 1021189 in patients with HFpEF suffering from worsening HF (SOCRATES-REDUCED) Middel BAY-1021189 Populatie hartfalen Fase IIb Jaar aanvang 2013 Contactpersoon dr. J. Schaap (Cardioloog) Breda, Amphia Ziekenhuis
